| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 静注人免疫球蛋白(元) | 1,427,249,720.22 | 2,757,780,660.60 | 1,339,401,179.69 | 2,319,441,779.61 | 1,098,180,570.99 |
| 人血白蛋白(元) | 1,345,001,675.28 | 2,510,043,461.65 | 1,113,514,414.04 | 2,247,147,706.71 | 1,196,430,495.79 |
| 其他血液制品(元) | 328,176,756.35 | 744,927,106.24 | 377,910,613.65 | 595,474,256.07 | 387,831,647.98 |
| 营业成本(元) | |||||
| 静注人免疫球蛋白(元) | 716,161,890.48 | 1,187,317,750.86 | 569,339,483.26 | 1,151,215,889.32 | 592,217,459.52 |
| 人血白蛋白(元) | 793,289,242.89 | 1,224,900,446.36 | 527,467,489.77 | 1,152,826,881.01 | 667,330,655.99 |
| 其他血液制品(元) | 186,123,282.80 | 313,303,885.18 | 158,448,564.68 | 239,505,607.18 | 122,515,722.89 |
| 毛利(元) | |||||
| 静注人免疫球蛋白(元) | 711,087,829.74 | 1,570,462,909.74 | 770,061,696.43 | 1,168,225,890.29 | 505,963,111.47 |
| 人血白蛋白(元) | 551,712,432.39 | 1,285,143,015.29 | 586,046,924.27 | 1,094,320,825.70 | 529,099,839.80 |
| 其他血液制品(元) | 142,053,473.55 | 431,623,221.06 | 219,462,048.97 | 355,968,648.89 | 265,315,925.09 |
| 毛利率(%) | |||||
| 静注人免疫球蛋白(%) | 49.82 | 56.95 | 57.49 | 50.37 | 46.07 |
| 人血白蛋白(%) | 41.02 | 51.20 | 52.63 | 48.70 | 44.22 |
| 其他血液制品(%) | 43.29 | 57.94 | 58.07 | 59.78 | 68.41 |
| 收入构成(%) | |||||
| 静注人免疫球蛋白(%) | 46.03 | 45.87 | 47.31 | 44.93 | 40.94 |
| 人血白蛋白(%) | 43.38 | 41.75 | 39.34 | 43.53 | 44.60 |
| 其他血液制品(%) | 10.58 | 12.39 | 13.35 | 11.54 | 14.46 |
| 毛利构成(%) | |||||
| 静注人免疫球蛋白(%) | 50.62 | 47.77 | 48.88 | 44.61 | 38.91 |
| 人血白蛋白(%) | 39.27 | 39.10 | 37.20 | 41.79 | 40.69 |
| 其他血液制品(%) | 10.11 | 13.13 | 13.93 | 13.59 | 20.40 |